All In Biotech

Investigational drug · Phase 2

StromaForte

Also called: Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product, MSCs, Human Allogeneic Bone-Marrow -Derived Mesenchymal Stromal Cells Product

Not approved by FDA. In 5 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Cardiovascular Diseases, Frailty, Musculoskeletal Injury.

Phase 2

Last checked: Nov 19, 2026Latest source record: Apr 16, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

5

4 still active

All registered trials

5

Any phase or sponsor naming "StromaForte"

First trial start

2023

Oct 7, 2023

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "StromaForte", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Cardiovascular Diseases
  • Frailty
  • Musculoskeletal Injury
  • MSA - Multiple System Atrophy
  • MSA
  • Aging Frailty

Approved drugs for the same conditions: Cardiovascular and metabolic

Largest trials

Live from ClinicalTrials.gov: studies naming "StromaForte" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 43,663 on PubMed

Also in development for Cardiovascular Diseases

  • EloralintideLY3841136Phase 313 trials

    Eli Lilly · Obesity, Overweight, Diabetes Mellitus, Type 2

  • VicadrostatBI 690517Phase 35 trials

    Boehringer Ingelheim · Heart Failure, Diabetes Mellitus, Type 2, Hypertension

  • IRP101meta-fluorobenzylguanidine, 18F-MFBGPhase 34 trials

    Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) · Cardiovascular Diseases, Heart Failure, Ischemic Cardiomyopathy

  • LepodisiranLY3819469Phase 32 trials

    Eli Lilly · Atherosclerosis, Cardiovascular Diseases, Lipoprotein(a)

  • MosliciguatPhase 32 trials

    Pulmovant, Inc. · Pulmonary Hypertension, Interstitial Lung Disease, Vascular Diseases

  • RalinepagAPD811Phase 32 trials

    United Therapeutics · PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension

  • IMR-687Tovinontrine, CRD-750Phase 23 trials

    Cardurion Pharmaceuticals, Inc. · Heart Failure, Cardiovascular Diseases, Heart Diseases

  • SPC 2002Phase 21 trial

    Shin Poong Pharmaceutical Co. Ltd. · Hypertension, Essential, Cardiovascular Diseases, Cardiology

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.